Comparison of SP-A and LPS effects on the THP-1 monocytic cell line

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 279, Issue 1 23-1, 2000, Pages

  Song, Mingchen ^a   Phelps, David S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Innate immunity; Lipopolysaccharide; Surfactant protein A; Tolerance

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LUNG SURFACTANT EXTRACT; POLYMYXIN B; SURFACTANT PROTEIN A; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LEVEL; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL;

EID: 0033867334     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.2000.279.1.l110     Document Type: Article

References (36)

1. Antal JM, Divis LT, Erzurum SC, Wiedemann HP, and Thomassen MJ. Surfactant suppresses NF-kB activation in human monocytic cells. Am J Respir Cell Mol Biol 14: 374-379, 1996.
2. Blackwell TS, Blackwell TR, and Christman JW. Induction of endotoxin tolerance depletes nuclear factor-kB and suppresses its activation in rat alveolar macrophages. J Leukoc Biol 62: 885-891, 1997.
3. Blau H, Riklis S, Van Iwaarden JF, McCormack FX, and Kalina M. Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A. Am J Physiol Lung Cell Mol Physiol 272: L1198-L1204, 1997.
4. Cavaillon JM, Pitton C, and Fitting C. Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGF-β. J Endotoxin Res 1: 21-29, 1994.
5. Durando MM, Meier KE, and Cook JA. Endotoxin activation of mitogen-activated protein kinase in THP-1 cells; diminished activation following endotoxin desensitization. J Leukoc Biol 64: 259-264, 1998.
6. Fraher LJ, Borron P, Watson P, DeSousa D, Kiesel M, Veldhuizen RAW, Lewis JF, and Possmayer F. Surfactant associated protein A (SP-A) stimulates nitric oxide synthase (iNOS) in the mouse macrophage line J774 (Abstract). Am J Respir Crit Care Med 155: A804, 1997.
7. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 13: 1455-1476, 1999.
8. Haurum JS, Thiel S, Haagsman HP, Laursen SB, Larsen B, and Jensenius JC. Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein-A and comparison with two other collectins-mannan-binding protein and conglutinin. Biochem J 293: 873-878, 1993.
9. Hermans C and Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 159: 646-678, 1999.
10. Kalina M, Blau H, Riklis S, and Kravtsov V. Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions. Am J Physiol Lung Cell Mol Physiol 268: L144-L151, 1995.
11. Kastenbauer S and Ziegler-Heitbrock HWL. NF-kB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect Immun 67: 1553-1559, 1999.
12. Kohler NG and Joly A. The involvement of an LPS inducible IkB kinase in endotoxin tolerance. Biochem Biophys Res Commun 232: 602-607, 1997.
13. Koptides M, Umstead TM, Floros J, and Phelps DS. Surfactant protein A activates NF-κB in the THP-I monocytic cell line. Am J Physiol Lung Cell Mol Physiol 273: L382-L388, 1997.
14. Kremlev SG and Phelps DS. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol Lung Cell Mol Physiol 267: L712-L719, 1994.
15. Kremlev SG and Phelps DS. Effect of SP-A and surfactant lipids on expression of cell surface markers in the THP-1 monocytic cell line. Am J Physiol Lung Cell Mol Physiol 272: L1070-L1077, 1997.
16. Kremlev SG, Umstead TM, and Phelps DS. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol Lung Cell Mol Physiol 267: L357-L364, 1994.
17. Kremlev SG, Umstead TM, and Phelps DS. Surfactant protein A regulates cytokine production in the monocytic cell line THP-1. Am J Physiol Lung Cell Mol Physiol 272: L996-L1004, 1997.
18. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, and Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 158: 4336-4340, 1997.
19. LeVine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, Whitsett JA, and Korfhagen TR. Surfactant protein-A binds group B Streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 20: 700-708, 1999.
20. Li MH, Scatter SC, Manthei R, Bubrick M, and West MA. Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J Surg Res 57: 85-92, 1994.
21. McIntosh JC, Mervin-Blake S, Connor E, and Wright JR. Surfactant protein A protects growing cells and reduces TNF-α activity from LPS-stimulated macrophages. Am J Physiol Lung Cell Mol Physiol 271: L310-L319, 1996.
22. Phelps DS. Pulmonary surfactant modulation of host defense function. Appl Cardiopulm Pathophysiol 5: 221-229, 1995.
23. Randow F, Docke W-D, Bundschuh DS, Hartung T, Wendel A, and Volk H-D. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-γ, IL-12, and granulocyte-macrophage colony-stimulating factor. J Immunol 158: 2911-2918, 1997.
24. Thomassen MJ, Antal JM, Connors MJ, Meeker DP, and Wiedemann HP. Characterization of Exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophages cytokine responses. Am J Respir Cell Mol Biol 10: 399-404, 1994.
25. Thomassen MJ, Meeker DP, Antal JM, Connors MJ, and Wiedemann HP. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 7: 257-260, 1992.
26. Tino MJ and Wright JR. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 270: L677-L688, 1996.
27. Ulevitch RJ and Tobias PS. Recognition of endotoxin by cells leading to transmembrane signaling. Curr Opin Immunol 6: 125-130, 1994.
28. Van Golde LMG. Potential role of surfactant proteins A and D in innate lung defense against pathogens. Biol Neonate 67, Suppl 1: 2-17, 1996.
29. Van Iwaarden JF, Teding van Berkhout F, Whitsett JA, Oosting RS, and Van Golde LMG. A novel procedure for the rapid isolation of surfactant protein A with retention of its alveolar-macrophage-stimulating properties. Biochem J 309: 551-555, 1995.
30. Vogel SN, Kaufman EN, Tate MD, and Neta R. Recombinant interleukin-1 alpha and recombinant tumor necrosis factor-alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun 56: 2650-2657, 1988.
31. Welbourn CRB and Yong Y. Endotoxin, septic shock and acute lung injury: neutrophils, macrophages, and inflammatory mediators. Br J Surg 79: 998-1003, 1992.
32. Wiernik A, Curstedt T, Johansson A, Harstrand C, and Robertson B. Morphology and function of blood monocytes after incubation with lung surfactant. Eur J Respir Dis 71: 410-418, 1987.
33. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 77: 931-962, 1997.
34. Wright JR and Youmans DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol Lung Cell Mol Physiol 264: L338-L344, 1993.
35. Zhong WW, Burke PA, Hand AT, Walsh MJ, Hughes LA, Forse RA, Horn I, Billiar T, Rodriguez JL, and Hunt TK. Regulation of cytokine messenger RNA expression in lipopclysaccharide-stimulated human macrophages. Arch Surg 128: 158-164, 1993.
36. Ziegler-Heitbrock HWL. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45: 13-26, 1995.